vers la météo de la validation par utilisateur
+----------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-----------------------------------SUBJ:V-N-----------------------------------+ | +---------------OBJ:V-N---------------+ | +-------COMP:N-N(from)------+ | +-------MOD_ATT:N-ADJ------+ +-------------OBJ:V-N------------+---------COMP:N-N(of)--------+ | +-MOD_ATT:N-ADJ+ | | +----MOD_ATT:N-N---+ +-------OBJ:V-N-------+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_AT+ | | | +MOD_ATT:N-+ | +COMP:N-+ | | +MOD_AT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In plasma from ovulated female __SP__ exhibiting polycystic ovary syndrome , __NODE__ ( with a dosage of 100 mg/day ) decreases ( by 310.5 percent ) concentration of __SP__ __NODE__ protein . COMP:N-N(from) (plasma,__SP__) MOD_ATT:N-ADJ (__SP__,ovulate) MOD_ATT:N-ADJ (__SP__,female) OBJ:V-N (exhibit,__NODE__) MOD_ATT:N-ADJ (__NODE__,polycystic) MOD_ATT:N-N (__NODE__,ovary) MOD_ATT:N-N (__NODE__,syndrome) OBJ:V-N (with,mg/day) COMP:N-N(of) (dosage,@card@) COMP:V-N(In) (decrease,plasma) SUBJ:V-N (decrease,exhibit) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,concentration) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (concentration,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+----------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-----------------------------------SUBJ:V-N-----------------------------------+ | +---------------OBJ:V-N---------------+ | +-------COMP:N-N(from)------+ | +-------MOD_ATT:N-ADJ------+ +-------------OBJ:V-N------------+---------COMP:N-N(of)--------+ | +-MOD_ATT:N-ADJ+ | | +----MOD_ATT:N-N---+ +-------OBJ:V-N-------+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_AT+ | | | +MOD_ATT:N-+ | +COMP:N-+ | | +MOD_AT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In plasma from ovulated female __SP__ exhibiting polycystic ovary syndrome , __NODE__ ( with a dosage of 100 mg/day ) decreases ( by 310.5 percent ) concentration of __SP__ __NODE__ protein . COMP:N-N(from) (plasma,__SP__) MOD_ATT:N-ADJ (__SP__,ovulate) MOD_ATT:N-N (__SP__,female) OBJ:V-N (exhibit,__NODE__) MOD_ATT:N-ADJ (__NODE__,polycystic) MOD_ATT:N-N (__NODE__,ovary) MOD_ATT:N-N (__NODE__,syndrome) OBJ:V-N (with,mg/day) COMP:N-N(of) (dosage,@card@) COMP:V-N(In) (decrease,plasma) SUBJ:V-N (decrease,exhibit) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,concentration) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (concentration,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+----------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------COMP:V-N(from)------------------------------------+ | | +-----------------------------------SUBJ:V-N-----------------------------------+ | | +---------------OBJ:V-N---------------+ | | | | +-------MOD_ATT:N-ADJ------+ +-------------OBJ:V-N------------+---------COMP:N-N(of)--------+ | +-MOD_ATT:N-ADJ+ | | +----MOD_ATT:N-N---+ +-------OBJ:V-N-------+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_AT+ | | | +MOD_ATT:N-+ | +COMP:N-+ | | +MOD_AT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In plasma from ovulated female __SP__ exhibiting polycystic ovary syndrome , __NODE__ ( with a dosage of 100 mg/day ) decreases ( by 310.5 percent ) concentration of __SP__ __NODE__ protein . MOD_ATT:N-ADJ (__SP__,ovulate) MOD_ATT:N-ADJ (__SP__,female) OBJ:V-N (exhibit,__NODE__) MOD_ATT:N-ADJ (__NODE__,polycystic) MOD_ATT:N-N (__NODE__,ovary) MOD_ATT:N-N (__NODE__,syndrome) OBJ:V-N (with,mg/day) COMP:N-N(of) (dosage,@card@) COMP:V-N(In) (decrease,plasma) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,exhibit) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,concentration) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (concentration,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+----------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------COMP:V-N(from)------------------------------------+ | | +-----------------------------------SUBJ:V-N-----------------------------------+ | | +---------------OBJ:V-N---------------+ | | | | +-------MOD_ATT:N-ADJ------+ +-------------OBJ:V-N------------+---------COMP:N-N(of)--------+ | +-MOD_ATT:N-ADJ+ | | +----MOD_ATT:N-N---+ +-------OBJ:V-N-------+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_AT+ | | | +MOD_ATT:N-+ | +COMP:N-+ | | +MOD_AT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In plasma from ovulated female __SP__ exhibiting polycystic ovary syndrome , __NODE__ ( with a dosage of 100 mg/day ) decreases ( by 310.5 percent ) concentration of __SP__ __NODE__ protein . MOD_ATT:N-ADJ (__SP__,ovulate) MOD_ATT:N-N (__SP__,female) OBJ:V-N (exhibit,__NODE__) MOD_ATT:N-ADJ (__NODE__,polycystic) MOD_ATT:N-N (__NODE__,ovary) MOD_ATT:N-N (__NODE__,syndrome) OBJ:V-N (with,mg/day) COMP:N-N(of) (dosage,@card@) COMP:V-N(In) (decrease,plasma) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,exhibit) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,concentration) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (concentration,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+----------------------------------------------------COMP:V-N(In)---------------------------------------------------+ +-----------COMP:N-N(from)-----------+ | | +-----MOD_ATT:N-ADJ-----+ +-------MOD_ATT:N-ADJ------+----------------SUBJ:V-N----------------+-------------OBJ:V-N------------+---------COMP:N-N(of)--------+ | | +-MOD_ATT:N-ADJ-+ | +----MOD_ATT:N-N---+ +-------OBJ:V-N-------+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:+ | | +MOD_ATT:N-+ | +COMP:N-+ | | +MOD_AT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In plasma from ovulated female __SP__ exhibiting polycystic ovary syndrome , __NODE__ ( with a dosage of 100 mg/day ) decreases ( by 310.5 percent ) concentration of __SP__ __NODE__ protein . COMP:N-N(from) (plasma,exhibit) MOD_ATT:N-ADJ (exhibit,ovulate) MOD_ATT:N-ADJ (exhibit,female) MOD_ATT:N-ADJ (exhibit,__SP__) MOD_ATT:N-ADJ (__NODE__,polycystic) MOD_ATT:N-N (__NODE__,ovary) MOD_ATT:N-N (__NODE__,syndrome) OBJ:V-N (with,mg/day) COMP:N-N(of) (dosage,@card@) COMP:V-N(In) (decrease,plasma) SUBJ:V-N (decrease,__NODE__) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,concentration) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (concentration,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+----------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------MOD_ATT:N-N-------------+ | +-------COMP:N-N(from)------+ | +-------MOD_ATT:N-ADJ------+----------------SUBJ:V-N----------------+-------------OBJ:V-N------------+---------COMP:N-N(of)--------+ | +-MOD_ATT:N-ADJ+ | | +----MOD_ATT:N-N---+ +-------OBJ:V-N-------+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_AT+ | | | +MOD_ATT:N-+ | +COMP:N-+ | | +MOD_AT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In plasma from ovulated female __SP__ exhibiting polycystic ovary syndrome , __NODE__ ( with a dosage of 100 mg/day ) decreases ( by 310.5 percent ) concentration of __SP__ __NODE__ protein . COMP:N-N(from) (plasma,__SP__) MOD_ATT:N-ADJ (__SP__,ovulate) MOD_ATT:N-ADJ (__SP__,female) MOD_ATT:N-N (__NODE__,exhibit) MOD_ATT:N-ADJ (__NODE__,polycystic) MOD_ATT:N-N (__NODE__,ovary) MOD_ATT:N-N (__NODE__,syndrome) OBJ:V-N (with,mg/day) COMP:N-N(of) (dosage,@card@) COMP:V-N(In) (decrease,plasma) SUBJ:V-N (decrease,__NODE__) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,concentration) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (concentration,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+----------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------MOD_ATT:N-N-------------+ | +-------COMP:N-N(from)------+ | +-------MOD_ATT:N-ADJ------+----------------SUBJ:V-N----------------+-------------OBJ:V-N------------+---------COMP:N-N(of)--------+ | +-MOD_ATT:N-ADJ+ | | +----MOD_ATT:N-N---+ +-------OBJ:V-N-------+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_AT+ | | | +MOD_ATT:N-+ | +COMP:N-+ | | +MOD_AT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In plasma from ovulated female __SP__ exhibiting polycystic ovary syndrome , __NODE__ ( with a dosage of 100 mg/day ) decreases ( by 310.5 percent ) concentration of __SP__ __NODE__ protein . COMP:N-N(from) (plasma,__SP__) MOD_ATT:N-ADJ (__SP__,ovulate) MOD_ATT:N-N (__SP__,female) MOD_ATT:N-N (__NODE__,exhibit) MOD_ATT:N-ADJ (__NODE__,polycystic) MOD_ATT:N-N (__NODE__,ovary) MOD_ATT:N-N (__NODE__,syndrome) OBJ:V-N (with,mg/day) COMP:N-N(of) (dosage,@card@) COMP:V-N(In) (decrease,plasma) SUBJ:V-N (decrease,__NODE__) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,concentration) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (concentration,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+----------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +--------------------------------COMP:V-N(from)--------------------------------+ | +-----MOD_ATT:N-ADJ-----+ +-------MOD_ATT:N-ADJ------+----------------SUBJ:V-N----------------+-------------OBJ:V-N------------+---------COMP:N-N(of)--------+ | | +-MOD_ATT:N-ADJ-+ | +----MOD_ATT:N-N---+ +-------OBJ:V-N-------+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | | +MOD_ATT:+ | | +MOD_ATT:N-+ | +COMP:N-+ | | +MOD_AT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In plasma from ovulated female __SP__ exhibiting polycystic ovary syndrome , __NODE__ ( with a dosage of 100 mg/day ) decreases ( by 310.5 percent ) concentration of __SP__ __NODE__ protein . MOD_ATT:N-ADJ (exhibit,ovulate) MOD_ATT:N-ADJ (exhibit,female) MOD_ATT:N-ADJ (exhibit,__SP__) MOD_ATT:N-ADJ (__NODE__,polycystic) MOD_ATT:N-N (__NODE__,ovary) MOD_ATT:N-N (__NODE__,syndrome) OBJ:V-N (with,mg/day) COMP:N-N(of) (dosage,@card@) COMP:V-N(In) (decrease,plasma) COMP:V-N(from) (decrease,exhibit) SUBJ:V-N (decrease,__NODE__) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,concentration) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (concentration,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+----------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------COMP:V-N(from)------------------------------------+ | | +-------------MOD_ATT:N-N-------------+ | | | | +-------MOD_ATT:N-ADJ------+----------------SUBJ:V-N----------------+-------------OBJ:V-N------------+---------COMP:N-N(of)--------+ | +-MOD_ATT:N-ADJ+ | | +----MOD_ATT:N-N---+ +-------OBJ:V-N-------+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_AT+ | | | +MOD_ATT:N-+ | +COMP:N-+ | | +MOD_AT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In plasma from ovulated female __SP__ exhibiting polycystic ovary syndrome , __NODE__ ( with a dosage of 100 mg/day ) decreases ( by 310.5 percent ) concentration of __SP__ __NODE__ protein . MOD_ATT:N-ADJ (__SP__,ovulate) MOD_ATT:N-ADJ (__SP__,female) MOD_ATT:N-N (__NODE__,exhibit) MOD_ATT:N-ADJ (__NODE__,polycystic) MOD_ATT:N-N (__NODE__,ovary) MOD_ATT:N-N (__NODE__,syndrome) OBJ:V-N (with,mg/day) COMP:N-N(of) (dosage,@card@) COMP:V-N(In) (decrease,plasma) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,__NODE__) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,concentration) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (concentration,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)
+----------------------------------------------------COMP:V-N(In)---------------------------------------------------+ | +-------------------------------------COMP:V-N(from)------------------------------------+ | | +-------------MOD_ATT:N-N-------------+ | | | | +-------MOD_ATT:N-ADJ------+----------------SUBJ:V-N----------------+-------------OBJ:V-N------------+---------COMP:N-N(of)--------+ | +-MOD_ATT:N-ADJ+ | | +----MOD_ATT:N-N---+ +-------OBJ:V-N-------+ +----COMP:V-N(by)---+ | +-MOD_ATT:N-ADJ-+ | | +MOD_AT+ | | | +MOD_ATT:N-+ | +COMP:N-+ | | +MOD_AT+ | | +MOD_ATT+ | | | | | | | | | | | | | | | | | | | | In plasma from ovulated female __SP__ exhibiting polycystic ovary syndrome , __NODE__ ( with a dosage of 100 mg/day ) decreases ( by 310.5 percent ) concentration of __SP__ __NODE__ protein . MOD_ATT:N-ADJ (__SP__,ovulate) MOD_ATT:N-N (__SP__,female) MOD_ATT:N-N (__NODE__,exhibit) MOD_ATT:N-ADJ (__NODE__,polycystic) MOD_ATT:N-N (__NODE__,ovary) MOD_ATT:N-N (__NODE__,syndrome) OBJ:V-N (with,mg/day) COMP:N-N(of) (dosage,@card@) COMP:V-N(In) (decrease,plasma) COMP:V-N(from) (decrease,__SP__) SUBJ:V-N (decrease,__NODE__) COMP:V-N(by) (decrease,percent) OBJ:V-N (decrease,concentration) MOD_ATT:N-ADJ (percent,@card@) COMP:N-N(of) (concentration,protein) MOD_ATT:N-ADJ (protein,__SP__) MOD_ATT:N-ADJ (protein,__NODE__)